Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus

Pediatric Diabetes

Volumn 15, Issue 2, 2014, Pages 127-134

  Arbelaez, Ana Maria ^a,b   Xing, Dongyuan ^c   Cryer, Philip E ^a   Kollman, Craig ^c   Beck, Roy W ^c   Sherr, Jennifer ^d   Ruedy, Katrina J ^c   Tamborlane, William V ^d   Mauras, Nelly ^e   Tsalikian, Eva ^f   Wilson, Darrell M ^g   White, Neil H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c JAEB CENTER FOR HEALTH RESEARCH   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEMOURS CHILDREN S CLINIC   (United States)

^f UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Counterregulation; Epinephrine; Glucagon; Hypoglycemia; Type 1 diabetes mellitus

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; ANTIDIABETIC AGENT; INSULIN;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; GLUCAGON BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLYCEMIC CONTROL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE; MONITOR; PRIORITY JOURNAL; YOUNG ADULT; ADOLESCENT; CHEMICALLY INDUCED; CHILD; CLINICAL TRIAL; COMPLICATION; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DISEASE COURSE; FEMALE; MALE; METABOLISM; MULTICENTER STUDY;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; YOUNG ADULT;

EID: 84896396111     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12070     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. N Engl J Med 2005: 353: 2643-2653.
3. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008: 57: 3169-3176.
4. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007: 50: 1140-1147.
5. Donnelly L, Morris A, Frier B et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005: 22: 749-755.
6. Cryer PE. Death during intensive glycemic therapy of diabetes: mechanisms and implications. Am J Med 2011: 124: 993-996.
7. Sprague JE, Arbelaez AM. Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev 2011: 9: 463-473.
8. White N, Skor D, Cryer P, Levandoski LA, Bier D, Santiago J. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983: 308: 485-491.
9. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973: 182: 171-173.
10. Bolli G, de Feo P, Compagnucci P et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983: 32: 134-141.
11. Hoffman RP, Arslanian S, Drash AL, Becker DJ. Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM. J Pediatr Endocrinol 1994: 7: 235-244.
12. Siafarikas A, Johnston RJ, Bulsara MK, Leary P, Jones TW, Davis EA. Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care 2012: 35: 1757-1762.
13. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009: 32: S13-S61.
14. Sherr J, Tamborlane WV, Tsalikian E et al. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes. Diabetes Care 2012, In press.
15. Sherr J, Tsalikian E, Fox L et al. Dysregulation of α-cell function in youth during the first 2 years of T1D: reciprocal abnormalities in glucagon responses to mixed meal feedings and hypoglycemia. Diabetes 2012: 61: A52-A53.
16. Shah SD, Clutter WE, Cryer PE. External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med 1985: 106: 624-629.
17. Sherr J, Tamborlane WV, Xing D et al. Achievement of target A1c levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care 2012: 35: 817-820.
18. Cryer PE. Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 2012: 153: 1039-1048.
19. Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM). J Pediatr Endocrinol 1994: 7: 225-234.